Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders

NCT ID: NCT00929929

Last Updated: 2014-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-12-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a nutritional supplement with an amino acid called leucine along with resistance exercise are effective in the improvement of muscle strength and quality of life in elderly people.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Physiological aging is accompanied by functional loss and changes in different organs, including the skeletal muscle, with a progressive reduction in muscle mass. This is called physiological sarcopenia of the elderly.

In any population of autonomous individuals over 65 years, a proportion between 3% and 32% depending on age, meets the criteria of the so-called Frailty Syndrome. Frailty is characterized by a decrease in reserves and resistance to aggression, conferring increased vulnerability, disability and poor vital prognosis.

A feature of the Frailty Syndrome is the potential reversibility of many of the elements at the initial stages of frailty. Currently, available treatment for frailty is limited. One of the tools should be the prevention of sarcopenia, where nutritional treatment and exercise have a vital role.

Protein synthesis in aged muscle can be improved by increasing leucine concentration above physiological levels by a higher intake. Regarding exercise, progressive resistance training is one of the interventions that have shown better results in the increase of mass and muscle strength in elderly people.

The hypothesis raises the possibility that an intervention consisting of a leucine supplement along with progressive resistance training, is superior to the same training program and a placebo in improving muscle strength and quality of life in elderly people.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ageing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

L-Leucine

This arm receives a supplement of leucine along with a progressive resistance exercise program.

Group Type EXPERIMENTAL

L-leucine.

Intervention Type DIETARY_SUPPLEMENT

10 g of leucine per day, during 12 weeks.

Exercise program.

Intervention Type BEHAVIORAL

Progressive resistance exercise program 4 days a week, during 12 weeks.

Maltodextrin

This arm receives a supplement of maltodextrin along with a progressive resistance exercise program.

Group Type PLACEBO_COMPARATOR

Maltodextrin.

Intervention Type DIETARY_SUPPLEMENT

10 g of maltodextrin per day, during 12 weeks.

Exercise program.

Intervention Type BEHAVIORAL

Progressive resistance exercise program 4 days a week, during 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

L-leucine.

10 g of leucine per day, during 12 weeks.

Intervention Type DIETARY_SUPPLEMENT

Maltodextrin.

10 g of maltodextrin per day, during 12 weeks.

Intervention Type DIETARY_SUPPLEMENT

Exercise program.

Progressive resistance exercise program 4 days a week, during 12 weeks.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Leucine. Maxijul. Resistance exercise.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 70 years of age.
* Subjects capable of doing resistance exercise.

Exclusion Criteria

* Hospitalized patients.
* Disabled patients (i.e., not being able to exercise).
* Patients that usually train in resistance exercise.
* Patients with chronic renal failure.
* Patients with a fractured extremity during the last 6 months.
* Patients that follow diets with a protein restriction.
* Patients with oral nutritional support, enteral or parenteral nutrition.
* Patients in a low calorie diet to lose weight.
* Patients using pharmacological treatment with anorexigenic effects, anabolic steroids or corticosteroids.
* Patients with cognitive impairment or major psychiatric disorder.
* Non-signed informed consent.
* Any patient not capable to properly follow the treatment or not considered adequate by the researchers.
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Clinic of Barcelona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pere Leyes

Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria T Forga, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Clinic of Barcelona

Joan Trabal, RD, MS

Role: STUDY_CHAIR

Hospital Clinic of Barcelona

Pere Leyes, MD

Role: STUDY_CHAIR

Hospital Clinic of Barcelona

Andreu Farran, PhD

Role: STUDY_CHAIR

University of Barcelona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nutrition and Dietetics Unit, Hospital ClĂ­nic de Barcelona

Barcelona, Catalonia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

Reference Type BACKGROUND
PMID: 11253156 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://en.wikipedia.org/wiki/Frailty_syndrome

A brief definition of the Frailty Syndrome.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FRA_LEU-09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrition and Exercise for Sarcopenia
NCT00872911 COMPLETED PHASE1
Resistance Training in Elderly
NCT00744094 COMPLETED PHASE1/PHASE2